AgingResearch.News
Brain agingCellsPreprint

Directly converted human neuronal spheroids preserve donor age and model Alzheimer disease

The three-dimensional cell platform maintains biological aging markers while spontaneously developing hallmark pathologies of sporadic Alzheimer disease.

bioRxiv · Alsolami S et al. · Paper published 1 Oct 2026

Paper

In a new preprint, researchers developed directly induced neuronal spheroids using primary fibroblasts from young, unimpaired aged, and sporadic Alzheimer disease human donors, as well as non-human primates. The team converted fibroblasts directly into three-dimensional neuronal spheroids without pluripotency. Single-nucleus RNA sequencing confirmed that approximately 96% of cells acquired a neuronal identity. The resulting electrophysiologically active neurons preserved donor-specific epigenetic age and supported astrocytes and microglia. Spheroids from Alzheimer donors spontaneously displayed neuronal degeneration, amyloid-beta accumulation, progressive Tau pathology, and metabolic dysfunction. Multi-omics profiling separated physiological aging from Alzheimer disease. Drug tests showed oxaliplatin shifted cells toward oxidative metabolism, and trametinib modulated inflammatory and age-associated programs.

Why it matters

Reprogramming cells through pluripotency typically erases biological age, obscuring how aging drives late-onset neurodegenerative disorders. By preserving donor epigenetic age, this three-dimensional model offers a system to study the intersection of human aging and dementia.

Caveats

The findings are based on an in vitro model described in a preprint that has not yet undergone peer review. The study relies on cultured spheroids rather than intact tissue from patients.

Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.

The paper

An age-preserving neuronal iSpheroid platform for modeling human aging and Alzheimer disease

Alsolami S, Wang M, Sarraf Sabedot T et al.

bioRxiv · 1 Oct 2026 · Preprint, not yet peer-reviewed

Relevance
Relevant
News value
Important
Evidence
Cells
Status
Preprint
See all